139 related articles for article (PubMed ID: 25552138)
1. Perforated levonorgestrel-releasing intrauterine system resulting in small bowel obstruction: a case report.
Loveless A; Dhari A; Kilpatrick CC
J Reprod Med; 2014; 59(11-12):611-3. PubMed ID: 25552138
[TBL] [Abstract][Full Text] [Related]
2. Management of a perforated levonorgestrel-medicated intrauterine device--a pharmacokinetic study: case report.
Haimov-Kochman R; Amsalem H; Adoni A; Lavy Y; Spitz IM
Hum Reprod; 2003 Jun; 18(6):1231-3. PubMed ID: 12773451
[TBL] [Abstract][Full Text] [Related]
3. Intrauterine contraception: incidence and factors associated with uterine perforation--a population-based study.
Kaislasuo J; Suhonen S; Gissler M; Lähteenmäki P; Heikinheimo O
Hum Reprod; 2012 Sep; 27(9):2658-63. PubMed ID: 22763376
[TBL] [Abstract][Full Text] [Related]
4. Management of levonorgestrel-releasing intrauterine system (LNG-IUS) uterine perforation.
Margarit LM; Griffiths AN; Vine SJ
J Obstet Gynaecol; 2004 Aug; 24(5):586-7. PubMed ID: 15369954
[No Abstract] [Full Text] [Related]
5. Intraperitoneal levonorgestrel-releasing intrauterine device following uterine perforation: the role of progestins in adhesion formation.
Haimov-Kochman R; Doviner V; Amsalem H; Prus D; Adoni A; Lavy Y
Hum Reprod; 2003 May; 18(5):990-3. PubMed ID: 12721174
[TBL] [Abstract][Full Text] [Related]
6. Cervical perforation by the strings of a levonorgestrel releasing-intrauterine system: a case report.
Gönenç I; Vural EZ; Aka N
Eur J Contracept Reprod Health Care; 2013 Oct; 18(5):415-8. PubMed ID: 23937289
[TBL] [Abstract][Full Text] [Related]
7. Complication rates associated with levonorgestrel intrauterine system use in adolescents with developmental disabilities.
Savasi I; Jayasinghe K; Moore P; Jayasinghe Y; Grover SR
J Pediatr Adolesc Gynecol; 2014 Feb; 27(1):25-8. PubMed ID: 24315712
[TBL] [Abstract][Full Text] [Related]
8. Body weight and composition in users of levonorgestrel-releasing intrauterine system.
Dal'Ava N; Bahamondes L; Bahamondes MV; de Oliveira Santos A; Monteiro I
Contraception; 2012 Oct; 86(4):350-3. PubMed ID: 22445431
[TBL] [Abstract][Full Text] [Related]
9. Does an intraabdominally placed LNG-IUS have an adverse effect on fertility? A case report.
Doris N; Shabib G; Corbett S; Leader A; Black A
Contraception; 2014 Jan; 89(1):63-6. PubMed ID: 24156885
[TBL] [Abstract][Full Text] [Related]
10. Perforation risk and intra-uterine devices: results of the EURAS-IUD 5-year extension study.
Barnett C; Moehner S; Do Minh T; Heinemann K
Eur J Contracept Reprod Health Care; 2017 Dec; 22(6):424-428. PubMed ID: 29322856
[TBL] [Abstract][Full Text] [Related]
11. Uterine perforation in women using a levonorgestrel-releasing intrauterine system.
Van Houdenhoven K; van Kaam KJ; van Grootheest AC; Salemans TH; Dunselman GA
Contraception; 2006 Mar; 73(3):257-60. PubMed ID: 16472566
[TBL] [Abstract][Full Text] [Related]
12. Selection and performance of the levonorgestrel-releasing intrauterine system.
Lähteenmäki P; Bardin CW; Elomaa K; Haukkamaa M; Kivijärvi A; Kuukankorpi A; Venhola M; Tuominen J
Acta Obstet Gynecol Scand Suppl; 1997; 164():69-74. PubMed ID: 9225643
[TBL] [Abstract][Full Text] [Related]
13. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E
Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
[TBL] [Abstract][Full Text] [Related]
14. Amenorrhoea despite displaced levonorgestrel intra-uterine system.
Bobrow C; Cooling H; Bisson D
Br J Fam Plann; 2000 Apr; 26(2):105-6. PubMed ID: 10773605
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of the forearm bone mineral density of long-term users of the levonorgestrel-releasing intrauterine system.
Bahamondes MV; Monteiro I; Castro S; Espejo-Arce X; Bahamondes L
Hum Reprod; 2010 May; 25(5):1158-64. PubMed ID: 20185512
[TBL] [Abstract][Full Text] [Related]
16. Transmural migration and perforation of a levonorgestrel intrauterine system: a case report and review of the literature.
Ferguson CA; Costescu D; Jamieson MA; Jong L
Contraception; 2016 Jan; 93(1):81-6. PubMed ID: 26386445
[TBL] [Abstract][Full Text] [Related]
17. Quantitative levonorgestrel plasma level measurements in patients with regular and prolonged use of the levonorgestrel-releasing intrauterine system.
Seeber B; Ziehr SC; Gschlieβer A; Moser C; Mattle V; Seger C; Griesmacher A; Concin N; Concin H; Wildt L
Contraception; 2012 Oct; 86(4):345-9. PubMed ID: 22402256
[TBL] [Abstract][Full Text] [Related]
18. Hysteroscopic management of displaced levonorgestrel-releasing intrauterine system.
Kuzel D; Hrazdirova L; Kubinova K; Dundr P; Cibula D; Mara M
J Obstet Gynaecol Res; 2013 May; 39(5):1014-8. PubMed ID: 23496334
[TBL] [Abstract][Full Text] [Related]
19. Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis.
Kelekci S; Kelekci KH; Yilmaz B
Contraception; 2012 Nov; 86(5):458-63. PubMed ID: 22832203
[TBL] [Abstract][Full Text] [Related]
20. Intravesical migration of levonorgestrel-releasing intrauterine system (LNG-IUS) with calculus formation.
Khan ZA; Khan SA; Williams A; Mobb GE
Eur J Contracept Reprod Health Care; 2006 Sep; 11(3):243-5. PubMed ID: 17056458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
